240 related articles for article (PubMed ID: 21908397)
1. Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase.
Ndongwe TP; Adedeji AO; Michailidis E; Ong YT; Hachiya A; Marchand B; Ryan EM; Rai DK; Kirby KA; Whatley AS; Burke DH; Johnson M; Ding S; Zheng YM; Liu SL; Kodama E; Delviks-Frankenberry KA; Pathak VK; Mitsuya H; Parniak MA; Singh K; Sarafianos SG
Nucleic Acids Res; 2012 Jan; 40(1):345-59. PubMed ID: 21908397
[TBL] [Abstract][Full Text] [Related]
2. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase.
Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG
Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic DNA synthesis fidelity of xenotropic murine leukemia virus-related virus reverse transcriptase.
Barrioluengo V; Wang Y; Le Grice SF; Menéndez-Arias L
FEBS J; 2012 Apr; 279(8):1433-44. PubMed ID: 22340433
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
Paprotka T; Venkatachari NJ; Chaipan C; Burdick R; Delviks-Frankenberry KA; Hu WS; Pathak VK
J Virol; 2010 Jun; 84(11):5719-29. PubMed ID: 20335265
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors.
Sluis-Cremer N; Sheen CW; Zelina S; Torres PS; Parikh UM; Mellors JW
Antimicrob Agents Chemother; 2007 Jan; 51(1):48-53. PubMed ID: 17088490
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations.
White KL; Chen JM; Margot NA; Wrin T; Petropoulos CJ; Naeger LK; Swaminathan S; Miller MD
Antimicrob Agents Chemother; 2004 Mar; 48(3):992-1003. PubMed ID: 14982794
[TBL] [Abstract][Full Text] [Related]
7. Xenotropic murine leukemia virus-related virus is susceptible to AZT.
Sakuma R; Sakuma T; Ohmine S; Silverman RH; Ikeda Y
Virology; 2010 Feb; 397(1):1-6. PubMed ID: 19959199
[TBL] [Abstract][Full Text] [Related]
8. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
Canard B; Sarfati SR; Richardson CC
J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
[TBL] [Abstract][Full Text] [Related]
9. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
11. K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanism.
Hachiya A; Kodama EN; Schuckmann MM; Kirby KA; Michailidis E; Sakagami Y; Oka S; Singh K; Sarafianos SG
PLoS One; 2011 Jan; 6(1):e16242. PubMed ID: 21249155
[TBL] [Abstract][Full Text] [Related]
12. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
Gao HQ; Sarafianos SG; Arnold E; Hughes SH
J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
[TBL] [Abstract][Full Text] [Related]
13. An enzymatically active chimeric HIV-1 reverse transcriptase (RT) with the RNase-H domain of murine leukemia virus RT exists as a monomer.
Misra HS; Pandey PK; Pandey VN
J Biol Chem; 1998 Apr; 273(16):9785-9. PubMed ID: 9545316
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
[TBL] [Abstract][Full Text] [Related]
16. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance.
Mas A; Parera M; Briones C; Soriano V; Martínez MA; Domingo E; Menéndez-Arias L
EMBO J; 2000 Nov; 19(21):5752-61. PubMed ID: 11060026
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of xenotropic murine leukaemia virus-related virus (XMRV) ribonuclease H.
Kim JH; Kang S; Jung SK; Yu KR; Chung SJ; Chung BH; Erikson RL; Kim BY; Kim SJ
Biosci Rep; 2012 Oct; 32(5):455-63. PubMed ID: 22724525
[TBL] [Abstract][Full Text] [Related]
18. Studies of molecular mechanism of tenofovir against 3TC- and AZT-resistance mutant HIV-1 reverse transcriptase.
Chong Y; Akula N; Chu CK
Bioorg Med Chem Lett; 2003 Nov; 13(22):4019-22. PubMed ID: 14592498
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors.
Hachiya A; Marchand B; Kirby KA; Michailidis E; Tu X; Palczewski K; Ong YT; Li Z; Griffin DT; Schuckmann MM; Tanuma J; Oka S; Singh K; Kodama EN; Sarafianos SG
J Biol Chem; 2012 Aug; 287(35):29988-99. PubMed ID: 22761416
[TBL] [Abstract][Full Text] [Related]
20. AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP.
Hartl MJ; Kretzschmar B; Frohn A; Nowrouzi A; Rethwilm A; Wöhrl BM
Nucleic Acids Res; 2008 Feb; 36(3):1009-16. PubMed ID: 18096624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
